🎗️ Breast Multimodality BI-RADS Synthesis (Mammo / DBT / US / MRI / CEM / CEUS)
UseWhen one patient has several breast imaging modalities and needs a single overall assessment.
SourceACR BI-RADS Atlas, 5th ed. 2013
This-shift next steps
After scoring: open the scene pack, peer scores, and the matching pathway. Local reference — no HIS write.
Paste the link in Slack, Teams, X, or LinkedIn — the preview image comes from this page’s Open Graph card.
Methodology · worked example, guidelines & full notes
Most abnormal finding wins.
When to use
When one patient has several breast imaging modalities and needs a single overall assessment.
How it works
Overall = most abnormal ACR modality; hierarchy 1<2<3<6<0<4A<4B<4C<5. CEUS is advisory only.
Key points
- Most abnormal finding wins.
- Hierarchy 1<2<3<6<0<4<5.
- Suspicious only on MRI/CEM → second-look US.
- CEUS is supplementary.
References
- [Guideline / primary source]ACR BI-RADS Atlas, 5th ed. 2013
- [Guideline / primary source]ACR BI-RADS CEM Supplement 2022
Worked calculation
The values below come from this tool's own example placeholders and are computed server-side with the formula shown on this page, so the arithmetic can be checked quickly. It demonstrates how to substitute values only — it is not clinical advice and not a real case.
| Mammography / DBT | 4A |
|---|---|
| Ultrasound | 4A |
| MRI | 4A |
| Contrast-enhanced mammography (CEM) | 4A |
| Contrast-enhanced US (not an ACR category; supplementary) | 4A |
→Overall BI-RADS4A
- Modalities:Mammo/DBT 4A · US 4A · MRI 4A · CEM 4A · CEUS 4A
- Driving modality:Mammo/DBT (BI-RADS 4A)
- Likelihood of malignancy:>2–≤10%
| Mammography / DBT | 0 — Incomplete |
|---|---|
| Ultrasound | 0 — Incomplete |
| MRI | 0 — Incomplete |
| Contrast-enhanced mammography (CEM) | 0 — Incomplete |
| Contrast-enhanced US (not an ACR category; supplementary) | 0 — Incomplete |
→Overall BI-RADS0
- Modalities:Mammo/DBT 0 · US 0 · MRI 0 · CEM 0 · CEUS 0
- Driving modality:Mammo/DBT (BI-RADS 0)
- Likelihood of malignancy:—
Verification & sources · governance
FAQ
Frequently asked questions
- What are the limits and cautions when using Breast Multimodality BI-RADS Synthesis (Mammo / DBT / US / MRI / CEM / CEUS)?
- For licensed clinicians and clinical researchers. Interpret results with history, investigations and local protocols; not a diagnosis or prescription, and not a substitute for multidisciplinary decision-making or local guidelines.
- Does Breast Multimodality BI-RADS Synthesis (Mammo / DBT / US / MRI / CEM / CEUS) upload patient data? Where is it calculated?
- Calculation runs locally in the browser; inputs and results are not uploaded. For licensed clinicians only; interpret with history, investigations and local protocols — not a diagnosis or prescription.
- How is Breast Multimodality BI-RADS Synthesis (Mammo / DBT / US / MRI / CEM / CEUS) calculated in practice? Can you show a worked example?
- Inputs: Mammography / DBT 4A, Ultrasound 4A, MRI 4A, Contrast-enhanced mammography (CEM) 4A, Contrast-enhanced US (not an ACR category; supplementary) 4A → Result: Overall BI-RADS 4A(Modalities: Mammo/DBT 4A · US 4A · MRI 4A · CEM 4A · CEUS 4A, Driving modality: Mammo/DBT (BI-RADS 4A), Likelihood of malignancy: >2–≤10%) Inputs: Mammography / DBT 0 — Incomplete, Ultrasound 0 — Incomplete, MRI 0 — Incomplete, Contrast-enhanced mammography (CEM) 0 — Incomplete, Contrast-enhanced US (not an ACR category; supplementary) 0 — Incomplete → Result: Overall BI-RADS 0(Modalities: Mammo/DBT 0 · US 0 · MRI 0 · CEM 0 · CEUS 0, Driving modality: Mammo/DBT (BI-RADS 0), Likelihood of malignancy: —)